Medicines, Ethics and Practice (MEP)

The latest edition of Medicines, Ethics and Practice (MEP) continues to evolve with many new, updated and revised sections.

The professional guide for pharmacists has been designed as an underpinning document to help pharmacists practise confidently and professionally. It embeds professionalism and professional judgement at the heart of the decision-making process.

The advice contained in MEP 38 intends to support day-to-day practice, rather than simply highlighting pharmacist’s statutory obligations. As such it will empower pharmacists, helping them to make the right decisions.

More importantly, MEP has been designed and developed with our members for our members.

Why pharmacists love the MEP

Find out more about...

What does MEP 38 cover?

  • Core Concepts and Skills
    • Patient or Person Centred Healthcare
    • Medicines Optimisation and Pharmaceutical Care
    • Professionalism and Professional Judgement
    • Clinical Check
    • Taking Medication Histories
    • Counselling Patients on Medicines
    • Getting the Culture Right
    • Professional Empowerment
    • Professional Development
    • Research Involvement
  • Underpinning Knowledge – Legislation and Professional Issues
    • Classification of Medicines
    • Professional and Legal Issues: Pharmacy Medicines
    • Professional and legal issues: Prescription- only medicines
    • Wholesale Dealing
    • Additional Legal and Professional Issues
    • Veterinary Medicines
    • Controlled Drugs
  • Royal Pharmaceutical Resources
  • Professional Standards
  • Excluded Topics and Signposting
  • Partnerships with Specialist Groups
  • Pharmacist Support
  • Appendices – GPhC Standards and Guidance

Back to top »

What's new in MEP 38?

The following new sections have been added to this year’s edition:

  • Medicines Optimisation (England) and Pharmaceutical Care (Scotland)
  • Professional Development (including information on CPD, RPS Faculty, RPS Foundation Pharmacy Framework, Developing Leadership and Mentoring)
  • Research Involvement
  • Signposting to information on existing electronic prescription systems
  • Dispensing a prescription in Welsh language
  • Administration of adrenaline in an emergency
  • GPhC Guidance for Registered  Pharmacies Preparing Unlicensed Medicines

Significant revisions have also been made to the following sections based on member feedback, changes to legislation, standards and policy development etc:

  • Appropriate practitioner includes podiatrist independent prescribers and physiotherapist independent prescribers
  • EEA and Swiss prescriptions requirements
  • MHRA regulatory statement “Guidance for pharmacists on the repeal of Section 10(7) of the Medicines Act 1968” (March 2014)
  • Controlled drug changes for Tramadol, Lisdexamfetamine, Zopiclone and Zaleplon
  • Running balance checks for zero balance stock.
  • Extemporaneous methadone
  • Within the section on Professional Standards revised information on Hospital Standards, new information on the new Public Health and Homecare Services Standards

Back to top »

MEP

Purchasing MEP

Are you interested in purchasing a copy of MEP 38? Did you know that all our Fellows, Members, Associates and Pharmaceutical Scientists receive a FREE personal copy of the MEP as part of their membership.

Find out more about membership »


If you’re not eligible to be a member of the Society but are interested in purchasing a copy of MEP, then please visit the Pharmaceutical Press website.

Buy MEP 38 today »

Correction: Information in the MEP 38 on podiatrist and physiotherapist independent prescribers being able to prescribe certain controlled drugs and unlicensed medicines has been corrected.

Find out more »